• OPEN AN ACCOUNT
Indian Indices
Sensex
77,966.35 -187.90
( -0.24%)
Global Indices
Nasdaq
53,805.64 -191.34
(-0.35%)
Dow Jones
7,747.95 -26.16
(-0.34%)
Hang Seng
67,546.56 576.34
(0.86%)
Nikkei 225
10,849.18 -13.32
(-0.12%)
Forex
USD-INR
95.28 0.13
(0.14%)
EUR-INR
110.05 0.08
(0.07%)
GBP-INR
128.64 0.30
(0.23%)
JPY-INR
0.60 0.00
(-0.45%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
146.19
465470.98
EPS(TTM)
Face Value()
Div & Yield %
13.27
1
0.82
 

IRB InvIT Fund consolidated net profit rises 3.29% in the March 2026 quarter
May 15,2026
Net profit of IRB InvIT Fund rose 3.29% to Rs 96.61 crore in the quarter ended March 2026 as against Rs 93.53 crore during the previous quarter ended March 2025. Sales rose 87.46% to Rs 528.18 crore in the quarter ended March 2026 as against Rs 281.75 crore during the previous quarter ended March 2025.

For the full year,net profit declined 4.77% to Rs 338.61 crore in the year ended March 2026 as against Rs 355.58 crore during the previous year ended March 2025. Sales rose 39.97% to Rs 1549.44 crore in the year ended March 2026 as against Rs 1107.01 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales528.18281.75 87 1549.441107.01 40
OPM %73.5082.47 -80.0282.47 -
PBDT236.52162.57 45 753.13618.79 22
PBT98.8896.71 2 373.28364.67 2
NP96.6193.53 3 338.61355.58 -5